232 related articles for article (PubMed ID: 25142616)
1. Onset of Huntington's disease: can it be purely cognitive?
Paulsen JS; Long JD
Mov Disord; 2014 Sep; 29(11):1342-50. PubMed ID: 25142616
[TBL] [Abstract][Full Text] [Related]
2. Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT-HD.
Long JD; Paulsen JS;
Mov Disord; 2015 Oct; 30(12):1664-72. PubMed ID: 26340420
[TBL] [Abstract][Full Text] [Related]
3. Huntington's disease: clinical presentation and treatment.
Novak MJ; Tabrizi SJ
Int Rev Neurobiol; 2011; 98():297-323. PubMed ID: 21907093
[TBL] [Abstract][Full Text] [Related]
4. The Addenbrooke's Cognitive Examination-Revised accurately detects cognitive decline in Huntington's disease.
Begeti F; Tan AY; Cummins GA; Collins LM; Guzman NV; Mason SL; Barker RA
J Neurol; 2013 Nov; 260(11):2777-85. PubMed ID: 23922130
[TBL] [Abstract][Full Text] [Related]
5. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
Tabrizi SJ; Scahill RI; Durr A; Roos RA; Leavitt BR; Jones R; Landwehrmeyer GB; Fox NC; Johnson H; Hicks SL; Kennard C; Craufurd D; Frost C; Langbehn DR; Reilmann R; Stout JC;
Lancet Neurol; 2011 Jan; 10(1):31-42. PubMed ID: 21130037
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychological manifestations of the genetic mutation for Huntington's disease in presymptomatic individuals.
Brandt J; Shpritz B; Codori AM; Margolis R; Rosenblatt A
J Int Neuropsychol Soc; 2002 Nov; 8(7):918-24. PubMed ID: 12405543
[TBL] [Abstract][Full Text] [Related]
7. Neurocognitive signs in prodromal Huntington disease.
Stout JC; Paulsen JS; Queller S; Solomon AC; Whitlock KB; Campbell JC; Carlozzi N; Duff K; Beglinger LJ; Langbehn DR; Johnson SA; Biglan KM; Aylward EH
Neuropsychology; 2011 Jan; 25(1):1-14. PubMed ID: 20919768
[TBL] [Abstract][Full Text] [Related]
8. Altered frontostriatal coupling in pre-manifest Huntington's disease: effects of increasing cognitive load.
Wolf RC; Sambataro F; Vasic N; Schönfeldt-Lecuona C; Ecker D; Landwehrmeyer B
Eur J Neurol; 2008 Nov; 15(11):1180-90. PubMed ID: 18754766
[TBL] [Abstract][Full Text] [Related]
9. Cognitive Control, Learning, and Clinical Motor Ratings Are Most Highly Associated with Basal Ganglia Brain Volumes in the Premanifest Huntington's Disease Phenotype.
Misiura MB; Lourens S; Calhoun VD; Long J; Bockholt J; Johnson H; Zhang Y; Paulsen JS; Turner JA; Liu J; Kara B; Fall E;
J Int Neuropsychol Soc; 2017 Feb; 23(2):159-170. PubMed ID: 28205498
[TBL] [Abstract][Full Text] [Related]
10. Effects of rivastigmine on motor and cognitive impairment in Huntington's disease.
de Tommaso M; Specchio N; Sciruicchio V; Difruscolo O; Specchio LM
Mov Disord; 2004 Dec; 19(12):1516-8. PubMed ID: 15390067
[TBL] [Abstract][Full Text] [Related]
11. Huntington's disease - clinical signs, symptoms, presymptomatic diagnosis, and diagnosis.
Shannon KM
Handb Clin Neurol; 2011; 100():3-13. PubMed ID: 21496568
[TBL] [Abstract][Full Text] [Related]
12. Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years.
Hart EP; Dumas EM; Giltay EJ; Middelkoop HA; Roos RA
J Huntingtons Dis; 2013; 2(2):137-47. PubMed ID: 25063511
[TBL] [Abstract][Full Text] [Related]
13. Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers.
Hahn-Barma V; Deweer B; Dürr A; Dodé C; Feingold J; Pillon B; Agid Y; Brice A; Dubois B
J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):172-7. PubMed ID: 9489526
[TBL] [Abstract][Full Text] [Related]
14. Cognitive decline in Huntington's disease expansion gene carriers.
Baake V; Reijntjes RHAM; Dumas EM; Thompson JC; ; Roos RAC
Cortex; 2017 Oct; 95():51-62. PubMed ID: 28843844
[TBL] [Abstract][Full Text] [Related]
15. Cognitive decline in prodromal Huntington Disease: implications for clinical trials.
Paulsen JS; Smith MM; Long JD;
J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1233-9. PubMed ID: 23911948
[TBL] [Abstract][Full Text] [Related]
16. Huntington's disease.
Ha AD; Fung VS
Curr Opin Neurol; 2012 Aug; 25(4):491-8. PubMed ID: 22772878
[TBL] [Abstract][Full Text] [Related]
17. Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study.
Lemiere J; Decruyenaere M; Evers-Kiebooms G; Vandenbussche E; Dom R
J Neurol; 2004 Aug; 251(8):935-42. PubMed ID: 15316797
[TBL] [Abstract][Full Text] [Related]
18. Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis.
Fusilli C; Migliore S; Mazza T; Consoli F; De Luca A; Barbagallo G; Ciammola A; Gatto EM; Cesarini M; Etcheverry JL; Parisi V; Al-Oraimi M; Al-Harrasi S; Al-Salmi Q; Marano M; Vonsattel JG; Sabatini U; Landwehrmeyer GB; Squitieri F
Lancet Neurol; 2018 Nov; 17(11):986-993. PubMed ID: 30243861
[TBL] [Abstract][Full Text] [Related]
19. Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease.
Zappacosta B; Monza D; Meoni C; Austoni L; Soliveri P; Gellera C; Alberti R; Mantero M; Penati G; Caraceni T; Girotti F
Arch Neurol; 1996 Jun; 53(6):493-7. PubMed ID: 8660149
[TBL] [Abstract][Full Text] [Related]
20. Cognitive and autonomic dysfunction in presymptomatic and early Huntington's disease.
Kobal J; Melik Z; Cankar K; Strucl M
J Neurol; 2014 Jun; 261(6):1119-25. PubMed ID: 24691902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
